Earnings Per Share (Tables)

6 Months Ended

Jun. 30, 2026

The following table sets forth the computation of basic and diluted net income per share (in thousands, except share and per

share amounts):


	Three Months Ended June 30,		Six Months Ended June 30,
	2026	2025	2026	2025
Basic:
Net income attributable to common stockholders	$16,899	$72,950	$56,749	$114,333
Weighted-average number of common shares	141,688,279	140,374,892	141,478,312	140,219,452
Net income per common share	$0.12	$0.52	$0.40	$0.82

Diluted:
Net income attributable to common stockholders	$16,899	$72,950	$56,749	$114,333
Weighted-average number of common shares	143,052,519	141,517,661	142,414,946	141,111,732
Net income per common share	$0.12	$0.52	$0.40	$0.81

The following table sets forth the components of the denominator for the computation of basic and diluted net income per

share for net income attributable to Ardent Health, Inc. stockholders:


		Three Months Ended June 30,		Six Months Ended June 30,
		2026	2025	2026	2025
Weighted-average number of common shares - basic		141,688,279	140,374,892	141,478,312	140,219,452
Effect of dilutive securities(1)		1,364,240	1,142,769	936,634	892,280
Weighted-average number of common shares - diluted		143,052,519	141,517,661	142,414,946	141,111,732

(1)	The effect of dilutive securities does not reflect weighted-average potential common shares from restricted stock and restricted stock units of 994,234 and 850,744 for the three months ended June 30, 2026 and 2025, respectively, and 2,488,145 and 641,768 for the six months ended June 30, 2026 and 2025, respectively, because their effect was antidilutive as calculated under the treasury stock method.